Tue, March 2, 2021
Mon, March 1, 2021
Fri, February 26, 2021
Thu, February 25, 2021
Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021

Jeffrey Hung Maintained (ACAD) at Buy with Increased Target to $65 on, Feb 25th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-65-on-feb-25th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jeffrey Hung of Morgan Stanley, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $60 to $65 on, Feb 25th, 2021.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Jeffrey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jeffrey


  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020
  • Danielle Brill of "Raymond James" Upgraded from Buy to Strong Buy and Held Target at $65 on, Monday, November 16th, 2020

Publication Contributing Sources